PT1855720T - Uso de um poxvírus modificado para a rápida indução de imunidade contra um poxvírus ou outros agentes infeciosos - Google Patents

Uso de um poxvírus modificado para a rápida indução de imunidade contra um poxvírus ou outros agentes infeciosos

Info

Publication number: PT1855720T
Authority: PT; Portugal
Prior art keywords: proxvirus; poxvirus; modified; infectious agents; immunity against
Prior art date: 2005-02-23

Application number

PT67070391T

Other languages

English (en)

Inventor

Mateo Luis

Chaplin Paul

Original Assignee

Bavarian Nordic As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-23

Filing date

2006-02-17

Publication date

2016-12-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34933889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1855720(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-02-17 Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As

2016-12-14 Publication of PT1855720T publication Critical patent/PT1855720T/pt

Links

230000036039 immunity Effects 0.000 title 1
230000006698 induction Effects 0.000 title 1
239000012678 infectious agent Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- A61K39/285—Vaccinia virus or variola virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Plant Pathology (AREA)
AIDS & HIV (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT67070391T 2005-02-23 2006-02-17 Uso de um poxvírus modificado para a rápida indução de imunidade contra um poxvírus ou outros agentes infeciosos PT1855720T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP05003873		2005-02-23

Publications (1)

Publication Number	Publication Date
PT1855720T true PT1855720T (pt)	2016-12-14

Family

ID=34933889

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT67070391T PT1855720T (pt)	2005-02-23	2006-02-17	Uso de um poxvírus modificado para a rápida indução de imunidade contra um poxvírus ou outros agentes infeciosos

Country Status (25)

Country	Link
US (3)	US20110142877A1 (pt)
EP (1)	EP1855720B2 (pt)
JP (3)	JP2008531489A (pt)
KR (1)	KR20070110007A (pt)
CN (1)	CN101128217B (pt)
AU (1)	AU2006218115B2 (pt)
BR (1)	BRPI0608310A2 (pt)
CA (1)	CA2593532C (pt)
CY (1)	CY1118573T1 (pt)
DK (1)	DK1855720T4 (pt)
EA (1)	EA013404B1 (pt)
ES (1)	ES2608627T5 (pt)
FI (1)	FI1855720T4 (pt)
HU (1)	HUE030037T2 (pt)
IL (1)	IL184347A (pt)
LT (1)	LT1855720T (pt)
MX (1)	MX2007010158A (pt)
MY (1)	MY162027A (pt)
NO (1)	NO347468B1 (pt)
NZ (1)	NZ556409A (pt)
PT (1)	PT1855720T (pt)
SI (1)	SI1855720T2 (pt)
UA (1)	UA100836C2 (pt)
WO (1)	WO2006089690A1 (pt)
ZA (1)	ZA200706078B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA100836C2 (ru) †	2005-02-23	2013-02-11	Бавариан Нордик А/С	Применение модифицированного вируса осповакцины анкара (mva) для быстрой индукции иммунитета против поксвирусных или других инфекционных агентов
US10183986B2 (en)	2005-12-15	2019-01-22	Industrial Technology Research Institute	Trimeric collagen scaffold antibodies
EP2073837B1 (en)	2006-10-06	2014-06-25	Bavarian Nordic Inc.	Recombinant modified vaccinia ankara virus encoding a her-2 antigen in combination with a taxane for use in treating cancer
US8268327B2 (en) *	2007-04-27	2012-09-18	Bavarian Nordic A/S	Immediate protection against pathogens via MVA
EP2111869A1 (en)	2008-04-23	2009-10-28	Stichting Sanquin Bloedvoorziening	Compositions and methods to enhance the immune system
CN105101993A (zh) *	2013-03-15	2015-11-25	巴法里安诺迪克有限公司	单次高剂量的mva在新生儿和婴儿中诱导保护性免疫反应
EP3116541B1 (en)	2014-03-12	2019-11-27	Bavarian Nordic A/S	Use of oil and water emulsions for increasing b cell responses with modified vaccinia ankara virus
FR3042121A1 (fr)	2015-10-08	2017-04-14	Jean-Marc Limacher	Composition anti-tumorale
FR3160186A1 (fr)	2024-03-13	2025-09-19	Odimma Therapeutics	Vecteur non-viral pour transcription augmentee

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2720361A1 (en) *	1999-11-12	2001-05-25	Oncolytics Biotech, Inc.	Viruses for the treatment of cellular proliferative disorders
US7097842B2 (en) *	2000-11-23	2006-08-29	Bavarian Nordic A/S	Modified vaccinia virus ankara for the vaccination of neonates
CN101676389A (zh) *	2000-11-23	2010-03-24	巴法里安诺迪克有限公司	改良安卡拉痘苗病毒变体
DK1420822T4 (en)	2002-04-19	2017-10-09	Bavarian Nordic As	Modified vaccinia virus Ankara for vaccination of newborns
PL218318B1 (pl) *	2002-05-16	2014-11-28	Bavarian Nordic As	Rekombinowany wirus krowianki Ankara (MVA), zawierająca go komórka, szczepionka lub kompozycja farmaceutyczna, sposób lub zestaw do jego otrzymywania, sekwencja DNA zawierająca genom tego wirusa oraz sposób wykrywania tego wirusa lub komórek nim zainfekowanych
AU2003264144C1 (en)	2002-09-05	2009-12-17	Bavarian Nordic A/S	Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
AU2003297499A1 (en) *	2002-12-23	2004-07-22	City Of Hope	Modified vaccinia ankara expressing p53 in cancer immunotherapy
US6960345B2 (en) *	2003-03-06	2005-11-01	Incell Corporation, Llc	Oral vaccinia formulation
EP1610816B1 (en) *	2003-03-28	2013-01-02	GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Mva virus expressing modified hiv envelope, gag, and pol genes
UA100836C2 (ru) †	2005-02-23	2013-02-11	Бавариан Нордик А/С	Применение модифицированного вируса осповакцины анкара (mva) для быстрой индукции иммунитета против поксвирусных или других инфекционных агентов
US8268327B2 (en)	2007-04-27	2012-09-18	Bavarian Nordic A/S	Immediate protection against pathogens via MVA

2006
- 2006-02-17 UA UAA200710500A patent/UA100836C2/ru unknown
- 2006-02-17 CN CN2006800058754A patent/CN101128217B/zh not_active Expired - Lifetime
- 2006-02-17 CA CA2593532A patent/CA2593532C/en not_active Expired - Lifetime
- 2006-02-17 ES ES06707039T patent/ES2608627T5/es not_active Expired - Lifetime
- 2006-02-17 DK DK06707039.1T patent/DK1855720T4/da active
- 2006-02-17 EP EP06707039.1A patent/EP1855720B2/en not_active Expired - Lifetime
- 2006-02-17 WO PCT/EP2006/001447 patent/WO2006089690A1/en not_active Ceased
- 2006-02-17 PT PT67070391T patent/PT1855720T/pt unknown
- 2006-02-17 NZ NZ556409A patent/NZ556409A/en not_active IP Right Cessation
- 2006-02-17 LT LTEP06707039.1T patent/LT1855720T/lt unknown
- 2006-02-17 BR BRPI0608310-2A patent/BRPI0608310A2/pt not_active Application Discontinuation
- 2006-02-17 AU AU2006218115A patent/AU2006218115B2/en not_active Expired
- 2006-02-17 JP JP2007555533A patent/JP2008531489A/ja active Pending
- 2006-02-17 SI SI200632128T patent/SI1855720T2/sl unknown
- 2006-02-17 NO NO20074855A patent/NO347468B1/no unknown
- 2006-02-17 KR KR1020077017385A patent/KR20070110007A/ko not_active Ceased
- 2006-02-17 FI FIEP06707039.1T patent/FI1855720T4/fi active
- 2006-02-17 EA EA200701801A patent/EA013404B1/ru not_active IP Right Cessation
- 2006-02-17 MX MX2007010158A patent/MX2007010158A/es active IP Right Grant
- 2006-02-17 HU HUE06707039A patent/HUE030037T2/en unknown
- 2006-07-20 MY MYPI20063481A patent/MY162027A/en unknown
2007
- 2007-07-02 IL IL184347A patent/IL184347A/en active IP Right Grant
- 2007-07-23 ZA ZA2007/06078A patent/ZA200706078B/en unknown
- 2007-08-23 US US11/892,479 patent/US20110142877A1/en not_active Abandoned
2011
- 2011-12-22 US US13/335,097 patent/US8808709B2/en active Active
2012
- 2012-07-10 JP JP2012154752A patent/JP5952112B2/ja not_active Expired - Lifetime
2014
- 2014-07-10 US US14/328,474 patent/US9265823B2/en not_active Expired - Lifetime
2016
- 2016-03-03 JP JP2016041014A patent/JP2016104822A/ja active Pending
- 2016-12-22 CY CY20161101335T patent/CY1118573T1/el unknown

Also Published As

Publication number	Publication date
HK1113466A1 (en)	2008-10-03
US9265823B2 (en)	2016-02-23
MX2007010158A (es)	2007-10-16
SI1855720T2 (sl)	2023-07-31
NZ556409A (en)	2010-09-30
FI1855720T4 (fi)	2023-08-31
EA200701801A1 (ru)	2008-02-28
CN101128217A (zh)	2008-02-20
CN101128217B (zh)	2012-04-25
NO20074855L (no)	2007-10-26
KR20070110007A (ko)	2007-11-15
SI1855720T1 (sl)	2017-01-31
ES2608627T3 (es)	2017-04-12
DK1855720T3 (da)	2017-01-16
WO2006089690A1 (en)	2006-08-31
MY162027A (en)	2017-05-31
AU2006218115B2 (en)	2012-08-02
AU2006218115A1 (en)	2006-08-31
IL184347A (en)	2016-07-31
ES2608627T5 (es)	2023-10-04
ZA200706078B (en)	2012-10-31
WO2006089690A9 (en)	2012-10-04
CA2593532A1 (en)	2006-08-31
JP2008531489A (ja)	2008-08-14
JP2016104822A (ja)	2016-06-09
DK1855720T4 (da)	2023-07-24
US20120107359A1 (en)	2012-05-03
IL184347A0 (en)	2007-10-31
CY1118573T1 (el)	2017-07-12
US20110142877A1 (en)	2011-06-16
EA013404B1 (ru)	2010-04-30
JP5952112B2 (ja)	2016-07-13
BRPI0608310A2 (pt)	2009-12-08
EP1855720B2 (en)	2023-04-26
LT1855720T (lt)	2017-01-10
JP2012193198A (ja)	2012-10-11
UA100836C2 (ru)	2013-02-11
EP1855720A1 (en)	2007-11-21
CA2593532C (en)	2017-05-02
NO347468B1 (no)	2023-11-13
HUE030037T2 (en)	2017-04-28
EP1855720B1 (en)	2016-10-05
US20140341946A1 (en)	2014-11-20
US8808709B2 (en)	2014-08-19

Publication	Publication Date	Title
IL184347A0 (en)	2007-10-31	Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
PL1968631T3 (pl)	2015-08-31	Szczepionka
ZA200902189B (en)	2010-02-24	Phenylpropionamide compounds and the use thereof
GB2423693B (en)	2008-01-30	Improved cookware
EP1784093A4 (en)	2009-02-25	DEVICE FOR RETURNING GLOVES
ZA200709207B (en)	2009-08-26	Vaccine
AP2699A (en)	2013-07-17	HIV vaccine
GB0526099D0 (en)	2006-02-01	"Hook"
GB0515135D0 (en)	2005-08-31	Vaccine
ZA200804099B (en)	2009-04-29	Multiclade HIV vaccines
GB0400537D0 (en)	2004-02-11	Le beanock/the beanock
ZA200709210B (en)	2009-04-29	Vaccine
ZA200805851B (en)	2010-04-28	Stress-reducer for shoulder and the use thereof
GB0608797D0 (en)	2006-06-14	Novel agents and the use thereof
GB0617996D0 (en)	2006-10-18	The hygienic trolley grip
GB2412851B (en)	2008-10-15	Pipework
GB0520783D0 (en)	2005-11-23	The clam
TWM277406U (en)	2005-10-11	Cookware
AU306184S (en)	2006-03-28	Induction unit
GB0505423D0 (en)	2005-04-20	The protector
PL377179A1 (pl)	2007-04-02	Stół podwieszony
PL374956A1 (pl)	2006-11-13	Sprzęgło indukcyjne
GB0525339D0 (en)	2006-01-18	Disposable articles
GB0502130D0 (en)	2005-03-09	Grip despensor
GB0410802D0 (en)	2004-06-16	The dust magnet